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Abstract 
Objectives: To evaluate the causes for low MMR vaccination coverage in the 9 Balkan States, and provide 
solutions for this public health concern. Methods: Credible articles published 5 years ago, from 2012 up to date 
were sought for, to ascertain and analyze information on the cause for low MMR vaccine coverage in the Balkan 
States, and also to provide strategies for mitigation. These journals were sought for in the following reference 
libraries available online: PubMed, EMBASE, CAB Abstracts, the World Health Organization, the Cochrane 
Library, Popline, European Centre for Disease Prevention and Control, Centre for Disease and Control, and 
Google/Google Scholar. Results: This study evaluated MMR vaccinations in nine Balkan States (Albania, Bosnia 
and Herzegovina, Bulgaria, Croatia, Macedonia, Montenegro, Slovenia, Serbia and Romania) from 2012 to 2016. 
While Albania ranked highest in maintaining the WHO recommended 95% vaccination coverage, other states 
fluctuated in their percentage of coverage with Bosnia and Herzegovina, Serbia, and Romania having the lowest 
coverage respectively. Conclusion: Socio-economic and Administrative factors have been the major challenge 
affecting MMR vaccination coverage in the Balkan States. Anti-vaccination movements recently increased their 
influence by encouraging the rejection of vaccination by parents. To curb these challenges, research institutes and 
governmental agencies should sensitize the society about the benefits of vaccination in children and further 
publicize clinical trials of vaccines in order to prove their safety and efficacy to the public. 
Keywords: MMR vaccination, vaccine coverage, measles, public health. 
 
Introduction 
MMR vaccine is a live attenuated vaccine developed against Measles, Mumps, and Rubella diseases. It is given to 
children to protect them against these diseases, with the first dose being given at 12 months, and the second dose 
at a maximum age of 6. [1] When the dosage is completed, the vaccine is expected to offer long-lived immunity 
to about 98% of children who are immunized.[2] Measles, Mumps, and Rubella are viral infections of public health 
concern, as they have contributed immensely to the global burden of disease in children. The prevalence of these 
infectious diseases have risen and fallen over time. For instance, in Romania throughout the year 2012, the country 
experienced fluctuating cases of measles; between January and February there was 84.9% decrease (cases per 
million)  in reported cases of measles in Romania, 488.18% increase in March, 51% decrease in April, 95.58% 
increase in May, and a decrease of 45.48% in June. [3] This decreasing trend continued until September, then in 
October, Romania recorded 155 measles cases, which was a 181.82% increase from September. [3] During this 
period, there was an outbreak of measles which affected children from ˂1 years old to 4 years. [4] This pattern has 
followed all the outbreaks in that region.[4] 
Amongst other Balkan states that have witnessed measles outbreaks both in the past, and at present is Bulgaria. 
They had an outbreak from 2009 to 2011, which affected a total of 24,364, predominantly children ˂15 years old. 
[5] The major reason for this outbreak according to the report was low vaccine coverage which led to a backlog of 
children susceptible to measles virus. [5] Of children within the age of 1-14 years, immunization of MMR vaccine 
was achieved with only 70% of the population who received just a single dose, while 22% were unvaccinated. [5] 
It was also reported that different cities in Macedonia had measles outbreak between 2010 and 2011, despite the 
high MMR vaccine coverage in the region. [6] Skopje in Macedonia had the highest reported measles case, with 
573 infected, followed by Strumica with 119 cases. [6] An accumulation of susceptible children between ˂1 to 4 
years in Skopje were identified to be the prevalent factor that led to the outbreak. All these measles outbreaks have 
had more prevalence on children within this age group, which reveals that there is a lag in MMR vaccination, and 
in the completion of two doses in children from ˂ 12 months old to 4 years.  
Also, the recent and ongoing measles outbreak which started in 2016 has affected all EU/EEA countries 
except Latvia and Malta. [7] The outbreak spread rapidly in the population affecting mostly children from below 
1 years to 4 years of age. Bulgaria has recorded a total of 166 cases, Romania 5605, and Slovenia 6 as shown on 
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Table 1. Of the 13,724 reported cases with known age, 37% of children below five years were affected, and 336.2 
cases per million children less than a year old were also affected, which is the highest incidence rate recorded so 
far. [7] Analyzing the prevalent circumstances for this outbreak, it was observed that it followed the same pattern 
as the previously recorded outbreaks. Children under the age of one had the highest unvaccinated rates - 96% - 
while 86% of children within one to four years were unvaccinated, and 11% were given one dose of MMR 
vaccination, while none completed the required two doses of the vaccination. [7] This reveals that there is a trend 
in the MMR vaccination in children that is yet to close up the immunity gap against measles. The purpose of this 
study is to analyze the reasons for the lapses in MMR vaccination coverage, through systematic study and 
evaluation of the available data. This report shall also discuss positive approaches that could be adopted to achieve 
the elimination goal of measles in the population. 
 
Materials and Methods 
A systematic review was conducted on peer-reviewed journals and credible articles published 5 years ago, from 
2012 and up to the current year, to identify and analyze information on the cause for low MMR vaccine coverage 
in the Balkan States, and also to provide strategies for mitigation. This journals were sought for in the following 
reference libraries available online: PubMed, EMBASE, CAB Abstracts, the World Health Organization, the 
Cochrane Library, Popline, European Centre for Disease Prevention and Control, Centre for Disease and Control, 
and Google/Google Scholar. The journal descriptions and abstracts were examined and segregated according to 
the exclusion and inclusion criteria such that only resources valuable to this study were retrieved. Quantitative data 
obtained from different Balkan countries were evaluated using an ANOVA to determine if the same circumstance 
is responsible for low MMR vaccine coverage in the region. 
The following exclusion criteria was applied on the journals retrieved during the search: journals published 
earlier than 2012, as well as those not specific to European region. While this study was specifically carried out to 
evaluate low coverage of MMR vaccination in some of the Balkan states, comparisons were made to other 
European countries. Also, MMR vaccination reported for adults, and its adverse reactions, were excluded from the 




The data obtained from the nine Balkan states reflecting the MMR vaccination coverage and measles outbreaks 
were tested with an ANOVA procedure. To ascertain if the mean of the values is significantly different across the 
differing countries, with the goal of determining if the data are under similar influences, thus allowing inferences 
regarding the reported causes. 
Table 1: ANOVA table 
 
Profiles of MMR immunization coverage in the Balkan states. 
Albania has maintained a steady optimum MMR immunization for children between the ages 12 – 23 months. 
From 2012 to 2016, Albania experienced 2% decrease from 2012 to 2016; however, the 95% sustainable level for 
MMR vaccine was exceeded throughout the five years under study. The highest MMR percentage coverage was 
observed in 2013, between 2012 and 2013 there was a percent increase, while 2014, 2015, and 2016 had a percent 
decrease preceding the following year (Table 2). 
Macedonian is the second ranked Balkan State in this study that met the preferred coverage level for MMR 
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vaccination. The 95% target was met twice, in 2012 and 2013. At the end of 2016, the state experienced a reduced 
percentage coverage of 14.6% from 2012. Bulgaria met the target only once, in 2013, and had a total reduced 
coverage of 2.1% from 2012 to 2016. Slovenia, as of 2016, had 1.1% more reduced coverage when compared to 
Bulgaria. 
Also, under the period of study, MMR vaccination coverage in Bosnia and Herzegovina declined from 2012 
to 2016. A 11.7% decrease was observed from 2012 to 2016, with the lowest percentage coverage being observed 
in 2015, a 6% decrease from 2014. Bosnia and Herzegovina, as well as Romania, Montenegro, and Serbia never 
met the 95% sustainable level for MMR vaccination coverage (Table 2). 
Generally, all of the identified Balkan States had a decline in MMR vaccination for children between 12 to 
23 months from 2012 to 2016. The resultant effect of this decreasing coverage is seen in the number of measles 
cases reported in these states (Table 3). Romania and Bulgaria recorded the highest number of measles cases 
between 2012 and 2016, while Albania had the fewest recorded measles cases. Montenegro had no official data 
on measles cases in this time period [8]. 
Table 2: % of Children Immunized Between the Age of 12 – 23 Months from 2012 – 2016 [9] 
 
 
Table 3: Measles cases in the Balkan States from 2012 to 2016 [10] 
YEAR 
2012 2013 2014 2015 2016 TOTAL 
COUNTRY 
Albania 9 0 - - 16 25 
Bosnia and 
Herzegovina 22 0 3000 1677 133 4832 
Bulgaria 1 14 0 219 1 235 
Croatia 2 1 18 206 4 231 
Montenegro - - - - - - 
Romania 3843 1159 59 7 2432 7500 
Serbia 0 1 37 383 11 432 
Slovenia 2 1 52 18 1 74 
Note: Albania lacks reported data for years 2014-2015, while Montenegro lacks 
reported data for all years from 2012-2016. 
 
Discussion 
The trend noticed in the immunization rates of the MMR vaccine across the Balkan states suggests a central cause. 
There is no particular trend detected in the other European countries regarding MMR vaccination. For instance, 
Germany, Hungary, and Spain have maintained more than the recommended 95% target with no net decrease from 
2012 to 2016. Hungary maintained 99% coverage throughout the five years under study, as well as Germany with 
97%, and Spain with 97%. Although Spain had a 2% decrease in 2013 from 97%, it still didn’t fall below the 95% 
MMR coverage level recommended by WHO [9] [11]  
ANOVA was utilized at a 95% confidence level to statistically establish the existence of significant 
differences in the data for deficient coverage of MMR vaccine in the Balkan states (Table 1). The calculated p 
values were ˃ .05, therefore, the null hypothesis was not rejected. It demonstrated that there are no statistically 
significant differences among the groups of data. This indicates that a set of common causes have led to a steady 
decline in MMR vaccination. The examination of MMR coverage in the individual states revealed varying 
YEAR
COUNTRY
Albania 98 99 98 97 96
Bosnia and 
Herzegovina 94 92 89 83 83
Bulgaria 94 95 93 92 92
Croatia 95 94 94 93 90
Macedonia 96 96 93 89 82
Montenegro 90 88 76 64 47
Romania 94 92 89 86 86
Serbia 87 92 86 86 82
Slovenia 95 94 94 94 92
2012 2013 2014 2015 2016
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Albania established their routine MMR vaccination in 1971, and they have since then managed to stay true 
to the plan; hence, the low number of measles outbreaks in the country. From 2012 to 2016, the region had few 
reported measles cases; however, this study shows that they had a reduced vaccine coverage of 2% from 2012 to 
2016. [12] This is a slight decrease, which can be attributed to a negligible cause. According to the research work 
by Pojani et al, [13] one of the early challenges Albania encountered in MMR immunization coverage was an 
insufficient supply of the vaccine, such that it wasn’t enough to immunize the children within the age group. This 
led to a national coverage below the 95% recommended level. [13] Also, Nelaj et al, observed reduced vaccination 
coverage in Albania from 2009 – 2010. [14] They reported that the major cause for the low vaccination coverage 
is the poor statistical data available in the region, existence of remote areas, and the high migration rate such that 
children fail to get vaccinated as scheduled. [14] 
Bosnia and Herzegovina didn’t meet the recommended 95% coverage in the period under study. In 2012, 94% 
MMR vaccination coverage was achieved, which reduced measles cases in the population. [15] Nevertheless, in 
subsequent years a lower vaccination coverage was noted, leading to more recorded outbreaks of measles. In 2014, 
3000 measles cases were reported in the region, which is also the same year where a reduced MMR vaccination 
coverage of 5.3% occurred. Bosnia and Herzegovina nosedived from 94% in 2012 to 83% in 2016, and during this 
downward transition, a major measles outbreak occurred from 2014 to 2015. [15][16] Hukic et al’s report on this 
outbreak made known that majority of the outbreak affected the unvaccinated population of the country, which 
amounted to 70% of the population, while 20% of the affected population had unknown vaccination status. [17] 
[18] The rationale for low MMR vaccination in the region was connected to the war effects, as well as parental 
influence in preventing their children from MMR vaccination. [19] Due to the recent controversies of 
developmental disorders surrounding MMR vaccination, parents hesitated to take their wards for immunization, 
thus contributing to low MMR vaccination in the region. [20] [21] 
The lifestyle of the population in Bulgaria and Romania is a predisposing factor to low vaccination coverage. 
[22][23] The technical report of ECDC grouped the population as nomadic, comprising of the highest population 
of Roma people. [24] Romania and Bulgaria have the highest population of Roma people, 8.32% and 10.33% 
respectively, and this group of people have been the most susceptible to measles outbreaks. [24] An outbreak of 
measles from March to August 2017 in Bulgaria, as reported by the National Measles Surveillance system, affected 
mostly the Roma population. Out of the 204 reported cases, 80.9% of which representing 165 children below 9 
years, resulted in the death of one child. [25] It was discovered that 41% of the reported cases were unvaccinated. 
[25] Their frequent travelling and migration makes it challenging to obtaining information on their vaccination 
and health status. In addition, these lifestyles cause difficulties in their access to health care which would benefit 
Roma children needing MMR vaccinations. In a study done to evaluate the effects of this health gap, it was 
observed that there is an evidently large difference in vaccination coverage between the Roma population and the 
non-Roma groups. [26] Roma children are less likely by 38.6% to be vaccinated with the MMR vaccine, which is 
explained to an extent by their socio-economic status. [26] It was affirmed that an increase to health care facilities 
will improve their immunization status. Also, the geographical settlements of these groups in rural areas are lacking 
healthcare providers. Other challenges that have contributed to low MMR vaccination coverage in the region are 
the poor health infrastructures, illiteracy (over 30% of Roma youths can’t read, write or speak Bulgarian well 
enough), administrative barriers seen in the low registration of Roma children with health facilities due to lack of 
identity documents and access to primary health care. 
 
Conclusion 
In this study, we examined the coverage rate of MMR vaccination in the Balkan states, incidence rates of measles 
cases, and attempted to ascertain possible causes for the low coverage. It was possible to determine that some of 
these causes leading to low MMR vaccination coverage are related to the existence of remote areas, lack of 
centralized information, ongoing wars in the region, and the nomadic lifestyle of the population. Statistical analysis 
suggests that these causes are common across countries in the region. 
Furthermore, recent controversies related to the side effects of MMR vaccinations have increased the low 
coverage of MMR vaccine in the Balkan states. These controversies resulted from a perceived lack of proper 
testing of vaccines to ascertain their safety and efficacy in humans. [27] The development of an anti-vaccination 
movement in Europe had a negative impact on parents’ attitude to MMR immunization. Their opinions on 
vaccinations are not proven, and they continue to misinform parents with several side effects of vaccinations. [28] 
Since humans generally depend on each other for personal experiences and information when it concerns infectious 
disease, the influence of these anti-vaccination movements have greatly affected the coverage of MMR vaccination 
in most Balkan states.[28] Based on recent research [29], educational programs aiming to improve the knowledge 
of parents in regards to immunization have led to significant and positive changes in terms of knowledge. Although 
research on this topic is still ongoing, it is a promising avenue of intervention to mitigate the impact of anti-
vaccination movements. Furthermore, training doctors on their specific approaches towards immunization has also 
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been shown to be an effective strategy – specifically, by recognizing the parents’ concerns, respecting their 
attitudes, and only afterwards attempting to correct their misconceptions regarding vaccination [30]. 
As suggested by most research, the total elimination of measles will occur through the process of herd 
immunity. Thus, measles must be eradicated in all countries according to the global eradication programme 
through continuous immunization by means of the MMR vaccine. This should involve implementing strategies 
that will closely keep track of the yearly scheduled vaccination for measles, such that the complete doses will be 
available based on the surveyed data for new births. Also, efforts should be made towards vaccinating children 
who are unvaccinated to close up every opportunity through which measles can re-infect the population. To close 
up the susceptible groups in the Balkan community, more efforts should be directed to improve the retrieval of 
data in the Roma population, and health policies should solve the challenge of proper education, housing and 
socio-economic status. One way to achieve this would be through the creation of vaccine registration systems 
which would send reminders on the vaccination schedule, while also providing immunization services in 
specialized medical stations, or, alternatively, by integrating health networks – to achieve this, civil society 
organizations can play a pivotal role by divulging information through underrepresented channels such as blogs 
and social media, acting as intermediaries between the experts and the general public [31]. Finally, to further curb 
these challenges, research institutes and governmental agencies should sensitize the society about the benefits of 
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